We strengthen Australia’s biosecurity
Boehringer awarded contract for FMD antigen bank
Search
Strengthening biosecurity with cutting-edge science
Strengthening Australia and New Zealand's biosecurity is crucial in preventing the spread of foot-and-mouth disease (FMD)
Bondi Junction response must include increased funding and support for severe mental illness
Voters want pre-election commitments for severe mental illness
Keith's Journey with Heart of Australia
Rural and remote medical needs in Australia
Better healthcare access for vulnerable communities in New Zealand
working with our partners in New Zealand to bring affordable diabetes medicine to people who need it most—and that includes indigenous Māori and Pacific Islander communities
Youth programs shape future farmers for success
Livestock producers in New Zealand are facing challenges that make it hard for the next generation to succeed as farmers. Rising costs, production pressures, and changes in industry practices are causing difficulties. However, a group of young farmers cal
Early diagnosis and a positive outlook: Bill’s story
Early diagnosis and a positive outlook: Bill’s story
HF Patient Story: Katrina
Patient story for HF sufferer Katrina
Empowering People, Making a Difference
VTI Day is a special event in Boehringer Ingelheim's cultural calendar
Putting a green spotlight on health
Boehringer Ingelheim’s new-generation reusable and propellant-free inhalers
Interconnected: The deep bond between cats and cat owners
We know there is a deep connection between humans and animals. But the relationship between cat owners and their cats can be especially complex, spanning physical and mental health as well as nuanced psychosocial dimensions.
Boehringer Ingelheim recognised as Top Employer for 2024
Boehringer Ingelheim Recognised as Top Employer for 2024, Demonstrating Strong Commitment to People Development in Australia and New Zealand
Product Defect Correction
Reporting of a Potential Defect in the Dose Counter: Spiriva Respimat® Solution for Inhalation 2.5ug
Accelerating gender equality at Boehringer Ingelheim
Accelerating gender equality at Boehringer Ingelheim
Human Health Products New Zealand
Human Health Products New Zealand
Working with Healthcare Professionals with Integrity and Passion
Working with Healthcare Professionals with Integrity and Passion
Expertise in Emergency and Exotic Animal Diseases
Expertise in Emergency and Exotic Animal Diseases
Transparency
Boehringer Ingelheim is committed to ethical and transparent interactions with healthcare professionals that supports the quality use of medicines and trust with stakeholders
Animal Health Products Australia
Animal Health Products Australia
Animal Health Products New Zealand
Animal Health Products New Zealand
The Future Of Workplace Inclusion
The Future Of Workplace Inclusion
The Future Of Workplace Inclusion
The Future Of Workplace Inclusion
TOP Employer 2023
TOP Employer 2023
Boehringer Ingelheim and Heart of Australia partnership to boost sustainability of rural healthcare
Boehringer Ingelheim and Heart of Australia partnership to boost sustainability of rural healthcare
Cardiovascular health
Click to access Pradaxa® (dabigatran etexilate) and Praxbind® (idarucizumab) HCP resources.